Related Experiment Videos
Clinical diversity of pyruvate dehydrogenase deficiency
J H Cross1, A Connelly, D G Gadian
1Neurosciences Unit, Institute of Child Health, London, United Kingdom.
Insights
Pyruvate dehydrogenase (PDH) deficiency presents with diverse neurological symptoms and varied imaging findings in children. Proton magnetic resonance spectroscopy consistently detected brain lactate, offering insights into this rare metabolic disorder.
Area of Science:
- Biochemistry
- Neurology
- Medical Genetics
Background:
- Pyruvate dehydrogenase (PDH) deficiency is a rare metabolic disorder affecting cellular energy production.
- The condition exhibits a wide spectrum of clinical manifestations, primarily impacting the neurological system.
- Understanding the variability in clinical presentation and biochemical markers is crucial for diagnosis and management.
Purpose of the Study:
- To characterize the clinical features, magnetic resonance findings, and biochemical profiles of children with PDH deficiency.
- To investigate the utility of proton magnetic resonance spectroscopy in detecting brain lactate in PDH deficiency.
- To explore the correlation between molecular genetics and clinical variability in PDH deficiency.
Main Methods:
- Clinical assessment of 7 children diagnosed with pyruvate dehydrogenase deficiency.
- Magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H-MRS) of the brain.
- Biochemical analyses to confirm PDH deficiency and assess metabolic status.
Main Results:
- Consistent neurological abnormalities were observed across all patients, despite diverse clinical presentations.
- Proton magnetic resonance spectroscopy revealed the presence of lactate in the brains of all six investigated children.
- Regional variations in brain lactate signals were noted in patients where multiple brain regions were examined.
- Molecular genetics studies provided potential explanations for the observed clinical heterogeneity.
Conclusions:
- Pyruvate dehydrogenase deficiency is characterized by significant clinical and neuroimaging variability.
- Brain lactate, detectable by proton magnetic resonance spectroscopy, is a consistent biochemical marker.
- Advances in molecular genetics are key to understanding the diverse phenotypes associated with PDH deficiency.
Abstract:
Clinical features, magnetic resonance, and biochemical studies are reported in 7 children with pyruvate dehydrogenase (PDH) deficiency. These findings confirm the diverse clinical presentation of this condition, although neurological abnormalities are consistent features. Imaging results are also varied. Six of the children were investigated with proton magnetic resonance spectroscopy and lactate was demonstrated in brain in all patients. Regional variation in the lactate signal was observed in those patients in whom 2 regions were examined. Advances in molecular genetics have provided some explanations for the clinical variation in pyruvate dehydrogenase deficiency.